Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?

Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?

Visa andra versioner (1)

Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Montserrat Viñas-Bastart, Míriam Oms-Arias, Àfrica Pedraza-Gutiérrez, Irene Lizano-Díez, Eduardo L. Mariño, Pilar Modamio Charles
Materialtyp: Artikel
Språk:English
Publicerad: Fundación Pharmaceutical Care España 2022-06-01
Serie:Pharmaceutical Care España
Ämnen:
Off-label use; opioid; pharmacoepidemiology; primary health care; tramadol/dexketoprofen; drug combinations
Länkar:https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680

Internet

https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680

Liknande verk